Intraventricular clot removal with medication after brain bleed
Part of Brain & nervous system clinical trials.
This trial tests a clot-busting drug (rhTNK-tPA) to remove blood from the ventricles (fluid spaces deep in the brain) after a spontaneous brain bleed. It may help patients whose ventricles are blocked by a large clot, reducing pressure and improving recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a sudden brain bleed within the last 24 hours before your first CT scan.
- The bleed is spontaneous (not caused by a tumor, aneurysm, or other known cause).
- The clot in the fluid spaces of your brain is larger than 20 milliliters and is blocking the flow of fluid.
- You have a drain placed in the fluid space of your brain (external ventricular drain) before joining the study.
- Your blood pressure is stable (below 180 mmHg) for at least 6 hours before enrollment.
- You have not taken blood thinners (like warfarin, dabigatran, rivaroxaban, or clopidogrel) in the past week (aspirin is okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a method to actively flush (irrigate) and help remove an active brain bleed inside the brain. It may help some adults recover better by improving how the blood is cleared after bleeding starts.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
This trial tests a minimally invasive procedure using a special clot-busting medicine (tenecteplase) for a certain type of brain bleed. It aims to see if this approach improves recovery compared to standard care.
This trial tests whether giving tranexamic acid (a medicine that helps clots stay stable) along with intensive blood pressure lowering can reduce bleeding in the brain and improve recovery. It is for people who arrive at the hospital very quickly after a hemorrhagic stroke.
This trial tests a rapid procedure to remove a blood clot in the brain after a specific type of stroke. It might help people with a moderate-sized bleed in the front part of the brain if treatment can start within 24 hours.
This trial tests a clot-busting drug called tenecteplase to see if it can safely treat a large brain bleed (intracerebral hemorrhage). It may help people who had a bleed within the last 24 hours and whose CT scans show the bleed has stopped growing.
Hear when a new Intraventricular Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.